Literature DB >> 30403270

Effect of lifestyle interventions on diabetic peripheral neuropathy in patients with type 2 diabetes, result of a randomized clinical trial.

Haleh Ghavami, Moloud Radfar, Soraya Soheily, Shams Aldin Shamsi1, Hamid Reza Khalkhali.   

Abstract

OBJECTIVES: Diabetic peripheral neuropathy (DPN) is the most common and troublesome complication of diabetes leading to great morbidity and resulting in a huge economic burden for diabetes care. Over half of people with diabetes develop neuropathy. Also, DPN is a major cause of reduced quality of life due to pain, sensory loss, gait instability, fall-related injury, and foot ulceration and amputation. The aim of this study was evaluating the effects of lifestyle interventions on diabetic neuropathy severity in diabetes type 2 outpatients.
METHODS: This clinical trial conducted on 74 patients with DPN that divided with random allocation into intervention or control group. The lifestyle interventions applied in the intervention group beginning four educational sessions on lifestyle that emphasize strategies for lowering blood sugar, increasing physical activity, promoting weight loss, prudent diet, and foot caring. Each session was lasted for1.5 hour. Then patients followed for 12 weeks. During this period, they received counseling on mentioned lifestyle interventions. DPN severity in both groups measured using modified Toronto Clinical Neuropathy Score (mTCNS) at the beginning of study and at the end of counseling for 12 weeks.
RESULTS: Comparing differences of mean of DNP severity before and after lifestyle intervention between two groups of study, there was a significant difference (p<0.001). DNP severity in control group had not any change or it increased in some participants, but DNP decreased in intervention group, after applying lifestyle intervention.
CONCLUSION: Lifestyle interventions can contribute to reducing DPN severity, and consequently decreasing neuropathic pain.

Entities:  

Mesh:

Year:  2018        PMID: 30403270     DOI: 10.5505/agri.2018.45477

Source DB:  PubMed          Journal:  Agri        ISSN: 1300-0012


  7 in total

Review 1.  Complementary and Alternative Medicine for Painful Peripheral Neuropathy.

Authors:  Vanessa Baute; Danielle Zelnik; Jarret Curtis; Fatemeh Sadeghifar
Journal:  Curr Treat Options Neurol       Date:  2019-09-02       Impact factor: 3.598

2.  Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy.

Authors:  Lili Song; Rui Han; Hongqing Yin; Jingfang Li; Yue Zhang; Jiayi Wang; Zhen Yang; Junwei Bai; Maojuan Guo
Journal:  Metabolomics       Date:  2022-05-20       Impact factor: 4.290

Review 3.  Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies.

Authors:  Kelley Newlin Lew; Tracey Arnold; Catherine Cantelmo; Francky Jacque; Hugo Posada-Quintero; Pooja Luthra; Ki H Chon
Journal:  J Diabetes Sci Technol       Date:  2022-01-07

Review 4.  A review of nutrition in neuropathic pain of leprosy.

Authors:  Michael Klowak; Andrea K Boggild
Journal:  Ther Adv Infect Dis       Date:  2022-06-01

5.  Interventions for promoting physical activity in people with neuromuscular disease.

Authors:  Katherine Jones; Fiona Hawke; Jane Newman; James Al Miller; Joshua Burns; Djordje G Jakovljevic; Grainne Gorman; Douglass M Turnbull; Gita Ramdharry
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

6.  A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes.

Authors:  Yang Liu; Ling-Ling Meng; Jian-Wei Li; Yin-Shan Jin; Rui-Hua An
Journal:  Dis Markers       Date:  2022-07-15       Impact factor: 3.464

Review 7.  Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2019-12-01       Impact factor: 4.232

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.